SHAREHOLDER ALERT: Law firm Pomerantz is investigating

NEW YORK, April 28, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors in Synopsys, Inc. (“Synopsys” or the “Company”) (NASDAQ: SNPS). Such investors are advised to contact Robert S. Willoughby at or 888-476-6529 ext. 7980.

The investigation focuses on whether Synopsys and certain of its officers and/or directors have engaged in securities fraud or other illegal business practices.

[Click here for information about joining the class action]

On April 13, 2022, Bloomberg published an article reporting that Synopsys “is under investigation by the U.S. Department of Commerce for possibly passing key technology to banned Chinese companies.” Quoting “people familiar with the matter”, the article reports that “[i]Investigators are investigating allegations that Synopsys, together with subsidiaries in China, provided chip designs and software to Huawei Technologies Co.’s HiSilicon unit for manufacturing at Semiconductor Manufacturing International Corp. As the article notes, “US companies are prohibited from selling certain types of technology to Huawei and SMIC because they have been designated as national security threats by the Office of Industry and Security of the United States. Commerce Department“. At this news, Synopsys’ stock price fell sharply over the next two trading sessions.

Pomerantz LLP, with offices in New York, Chicago, Los Angeles, Paris and Tel Aviv, is recognized as one of the leading firms in the areas of corporate litigation, securities and antitrust. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions. Today, more than 85 years later, Pomerantz continues the tradition he established, fighting for the rights of victims of securities fraud, breaches of fiduciary duty and corporate misconduct. The firm recovered numerous multimillion-dollar damages on behalf of class members. To see

Robert S. Willoughby
Pomerantz LLP
888-476-6529 ext. 7980